247 filings
Page 4 of 13
8-K
b2qjq9cz5zvj
27 Mar 20
Departure of Directors or Certain Officers
4:41pm
8-K
63zkhs2tk8 qnbh85
18 Mar 20
NewLink Genetics Stockholders Approve Merger with Lumos Pharma
4:37pm
8-K
6g9z1gavv 70
28 Feb 20
NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
9:08am
8-K
smhxdonnwjxpho1vxsn
20 Dec 19
Regulation FD Disclosure
4:21pm
8-K/A
scp4zw9t0saz2ya2l3e
20 Nov 19
Regulation FD Disclosure
6:11am
8-K
94ld5wjx 8p9hdktbj0m
20 Nov 19
Entry into a Material Definitive Agreement
6:08am
8-K
4aford
12 Nov 19
Other Events
9:11am
8-K
uflzwiy990qwhlu1b
6 Nov 19
NewLink Genetics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
8:34am
8-K
t73zir26h97n
30 Sep 19
Entry into a Material Definitive Agreement
12:00am
8-K
p50fy8m 5id
17 Sep 19
Other Events
5:16pm
8-K
7n4i7nb0dn6
2 Aug 19
Departure of Directors or Certain Officers
4:24pm
8-K
z42qq2by blc3
30 Jul 19
NewLink Genetics Provides Corporate Update and Reports Second Quarter 2019 Financial Results
8:36am
8-K
0u34kuaafi9pb4gws0
23 May 19
NewLink Genetics Presents Updated NLG802 Results at the Immuno-Oncology 2019 World Congress
8:40am
8-K
tqo nqjbtln
15 May 19
Submission of Matters to a Vote of Security Holders
5:02pm
8-K
vy92izr 96
8 May 19
NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update
4:33pm
8-K
tumurtt
2 Apr 19
NewLink Genetics Presents Encouraging Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019
8:32am
8-K
6jz8jzaeghg2b0i5sg4f
5 Mar 19
Departure of Directors or Certain Officers
4:27pm
8-K
buorld 61t
27 Feb 19
NewLink Genetics Announces Clinical Trial Abstract Presentation at AACR Annual Meeting
5:15pm
8-K
qmfs2dja a6nxcf2pwgu
27 Feb 19
NewLink Genetics Reports Fourth Quarter, Year-End 2018 Financial Results and Provides Update for Clinical Programs
4:41pm
8-K
m3dzi1
17 Jan 19
Entry into a Material Definitive Agreement
4:27pm